United StatestraZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 tablets (NDC 50111-560-01), Lot 1394026, Exp. 02/2028, manufactured by Pliva Hrvatska d.o.o. for Teva Pharmaceuticals, are being recalled. The recall was issued for the presence of foreign tablets/capsules and covers 175,392 bottles distributed nationwide in the United States.
What's being recalled
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
Recalling firm: Teva Pharmaceuticals USA, Inc, Parsippany, NJ, United States.
How to identify it
Lot: 1394026, Exp. 02/2028.
The hazard
Presence of Foreign Tablets/Capsules
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)